Nabla Bio
YC S20We use AI to design antibodies for intractable diseases
Boston, MA, USAFounded 20218 employeeswww.nabla.bio
Team
8
Founded
2021
About
Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.
Tags
AI-powered Drug Discovery Healthcare
No open roles at this time.
Similar Healthcare startups
Kernal Biologics
Kernal is creating mRNA 2.0 therapies that work in specific cells
Artificial IntelligenceBiotechGenomics
Open Jobs —
Team 20
Founded 2020
SiPhox Health
Wearable and At-Home health monitoring with silicon photonic chips
Hard TechBiometricsNanosensors
Open Jobs —
Team 63
Founded 2020
Known Medicine
Combining 3D cell culture & AI to translate drugs to clinical success
AI-powered Drug DiscoveryOncology
Open Jobs —
Team 17
Founded 2020
adyn
The first test designed to prevent birth control side effects
Fertility TechMachine LearningConsumer Health Services
Open Jobs —
Team 7
Founded 2020